← Leaderboards
Brian H Kushner
Mabvax Therapeutics, Inc.
$49,717
Attributed
$149,152
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$149,152 · 1
By mechanism
R43$149,152 · 1
Top collaborators
- Philip O. Livingston1 shared
- Govind Ragupathi1 shared
Others in their field
Top investigators on “Adjuvant Chemotherapy”
- Norman Wolmark · Nsabp Foundation, Inc.$107,217,987
- Walter John Curran · Thomas Jefferson University$27,327,059
- Laurence H Baker · University Of Michigan At Ann Arbor$22,023,724
- Philip J Disaia · University Of California Irvine$19,978,203
- Daniel W Nixon · Medical University Of South Carolina$16,979,710
- Robert C Park · American College Of Ob And Gyn$16,339,593
Research focus
Adjuvant ChemotherapyAntibodiesAntibody FormationAntigensBeta-GlucansCancer CellCancer PatientCancer VaccinesClinical ProtocolsClinical TrialsCombined Modality TherapyDisease RemissionDoseDouble-Blind MethodEmbryoFoundationsGanglioside Gd2ImmunizationImmunogenicityImmunologic AdjuvantsIn Complete RemissionInstitutional Review BoardsKeyhole Limpet HemocyaninAdjuvant